NEW YORK, March 14, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding CVS Caremark Corporation (NYSE: CVS), Walgreen Company (NYSE: WAG), Rite Aid Corporation (NYSE: RAD), GNC Holdings Inc (NYSE: GNC), and Cardinal Health Inc (NYSE: CAH). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
--
CVS Caremark Corporation Analyst Notes
On March 6, 2014, CVS Caremark Corporation (CVS Caremark) announced that its board of directors approved a quarterly dividend of $0.275 per share on the corporation's common stock, payable on May 2, 2014 to holders of record on April 22, 2014. The full analyst notes on CVS Caremark Corporation are available to download free of charge at:
http://www.AnalystsReview.com/03142014/CVS/report.pdf
--
Walgreen Company Analyst Notes
On March 5, 2014, Walgreen Company (Walgreens) released its February 2014 store sales report. According to Walgreens, its sales rose 5.0% YoY to $6.05 billion, while total front-end sales were up 3.0% YoY and comparable store front-end sales were up 2% YoY. Walgreens also released its Q2 FY 2014 (period ended February 28, 2014) total sales figures. The Company registered total sales of $19.6 billion for the quarter, up 5.2% YoY. Comparable store sales went up 4.5% YoY while front-end comparable store sales grew 2.0% YoY in Q2 FY 2014. Prescriptions filled at comparable stores and comparable pharmacy sales increased 2.4% YoY and 6.1% YoY, respectively. Further, for February, Walgreens reported that it has opened eight stores including five relocations. The full analyst notes on Walgreen Company are available to download free of charge at:
http://www.AnalystsReview.com/03142014/WAG/report.pdf
--
Rite Aid Corporation Analyst Notes
On March 10, 2014, Rite Aid Corporation (Rite Aid) announced its new pioneering health management program entitled "Rite Aid Health Alliance" that will provide comprehensive care and community-based health management to patients with chronic and poly-chronic health conditions, eventually helping them achieve health improvement goals. John Stradley, Rite Aid Chairman and CEO, said, "Through our innovative Rite Aid Health Alliance program, we will help patients with the resources and support necessary to successfully manage their conditions and improve their overall health and wellbeing." The full analyst notes on Rite Aid Corporation are available to download free of charge at:
http://www.AnalystsReview.com/03142014/RAD/report.pdf
--
GNC Holdings Inc. Analyst Notes
On March 4, 2014, GNC Holdings Inc. (GNC) announced that it has been named the top Health & Beauty franchise, and was also placed 7th overall, in the Top 100 Global Franchises list, making it at par with McDonald's, Dunkin' Donuts, and Wyndham Hotel Group. Currently, the Company has more than 1,000 franchise locations in the US, with franchise operations in more than 50 countries. Joseph Fortunato, GNC's Chairman, President & CEO, said, "This award highlights the commitment and hard work of all of our franchisees as well as the support our franchising group provides in helping to ensure their success and capitalize on our leading GNC global brands. Together, we have made the GNC Live Well brand one of the most respected retailing brands in the U.S., and this is a key competitive advantage for our franchisees." The full analyst notes on GNC Holdings Inc. are available to download free of charge at:
http://www.AnalystsReview.com/03142014/GNC/report.pdf
--
Cardinal Health Inc. Analyst Notes
On March 11, 2014, Cardinal Health Inc.'s (Cardinal Health) stock increased 0.10%, ending the day $72.54. Over the previous three trading sessions, the shares of the Company decreased 0.03%, in line with S&P 500 which also decreased 0.50% during the same trading period. The full analyst notes on Cardinal Health Inc. are available to download free of charge at:
http://www.AnalystsReview.com/03142014/CAH/report.pdf
--
About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
--
=============
EDITOR NOTES:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
- For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
AnalystsReview.com
SOURCE Analysts Review
